FDA.reportPublic FDA data

CYCLOPHOSPHAMIDE

Substance profile for UNII 8N3DW7272P, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CYCLOPHOSPHAMIDE
Structure render from PubChem CID 22420

Substance Identity#

UNII
8N3DW7272P
Preferred term
CYCLOPHOSPHAMIDE
Registry number
6055-19-2
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C7H15Cl2N2O2P.H2O
Chemical structure for CYCLOPHOSPHAMIDE
Structure render from PubChem CID 22420

Chemical And Database Identifiers#

SMILES
O.ClCCN(CCCl)P1(=O)NCCCO1
RxCUI
3002
PubChem
22420
NCIt
C405
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound22420pubchem.ncbi.nlm.nih.gov/compound/22420
RxNorm3002mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=3002
NCI ThesaurusC405ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C405
FDA Substance Registration System8N3DW7272Pprecision.fda.gov/uniisearch/srs/unii/8N3DW7272P

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE Tablets USP, 25 mg and 50 mg1
ACTIVE MOIETYCYCLOPHOSPHAMIDE Tablets USP, 25 mg and 50 mg1
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE TABLETS USP, 25 mg and 50 mg1
ACTIVE MOIETYCYCLOPHOSPHAMIDE TABLETS USP, 25 mg and 50 mg1
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]5
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE TABLET [ROXANE LABORATORIES, INC.]5
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE CAPSULE [ROXANE LABORATORIES, INC.]4
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [SANDOZ INC.]3
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]2
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]2
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]2
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]2
ACTIVE INGREDIENTCYCLOPHOSPHAMIDE CAPSULE [AVERA MCKENNAN HOSPITAL]1
ACTIVE INGREDIENTX (CYCLOPHOSPHAMIDE) POWDER [AX PHARMACEUTICAL CORP]1